Expression of Th-17 and RORγt mRNA in Behçet's Disease

Medical Science Monitor

Volumn 17, Issue 4, 2011, Pages 227-234

  Hamzaoui, Kamel ^a   Bouali, Eya ^a   Ghorbel, Imed ^b   Khanfir, Monia ^b   Houman, Habib ^b   Hamzaoui, Agnès ^a,c  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b LA RABTA HOSPITAL   (Tunisia)

^c ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

Author keywords

Beh et's Disease; Interleukin 17A; ROR t mRNA; Th17 cell

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 A; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEHCET DISEASE; BLOOD SAMPLING; CELL ADHESION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA NODOSUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH17 CELL; UMBILICAL VEIN ENDOTHELIAL CELL;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; FEMALE; HUMANS; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RNA, MESSENGER; TH17 CELLS; UP-REGULATION; YOUNG ADULT;

EID: 79953719113     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Yazici H, Yurdakul S, Hamuryudan, Fresko V: Behçet's syndrome, In: Hochberg MC, J. Silman A, Smolen JS et al. (eds.), Rheumatology, London: Mosby, 2003; 1665-69
2. Onder M, Gurer MA: The multiple faces of Behçet's disease and its etiological factors. J Eur Acad Dermatol Venereol, 2001; 15: 126-36
3. Suzuki N, Nara K, Suzuki T: Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease. Clin Med Res, 2006; 4: 147-51
4. Hamzaoui K, Hamzaoui A, Guemira F et al: Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol, 2002; 31: 205-10
5. Saruhan-Direskeneli G, Yentur SP, Akman-Demir G et al: Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol, 2003; 145: 127-34
6. Pène J, Chevalier S, Preisser L et al: Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol, 2008; 180: 7423-30
7. Harrington LE, Hatton RD, Mangan PR et al: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol, 2005; 6: 1123-32
8. Park H, Li Z, Yang XO et al: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol, 2005; 6: 1133-41
9. Murphy CA, Langrish CL, Chen Y et al: Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med, 2003; 198: 1951-57
10. Komiyama Y, Nakae S, Matsuki T et al: IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol, 2006; 177: 566-73
11. Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol, 2003; 171: 6173-77
12. Molet S, Hamid Q, Davoine F et al: IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol, 2001; 108: 430-38
13. Wong CK, Ho CY, Ko FW et al: Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol, 2001; 125: 177-83
14. Kotake S, Udagawa N, Takahashi N et al: IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest, 1999; 103: 1345-52
15. Chabaud M, Durand JM, Buchs N et al: Human interleukin-17: a T cellderived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum, 1999; 42: 963-70
16. Fujino S, Andoh A, Bamba S et al: Increased expression of interleukin 17 in inflammatory bowel disease. Gut, 2003; 52: 65-70
17. Andoh A, Takaya H, Makino J et al: Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells. Clin Exp Immunol, 2001; 125: 56-63
18. Kao CY, Chen Y, Thai P et al: IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol, 2004; 173: 3482-91
19. Faour WH, Mancini A, He QW, Di Battista JA: T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2(COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3'-untranslated region of COX-2 mRNA. J Biol Chem, 2003; 278: 26897-907
20. Shimada M, Andoh A, Hata K et al: IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J Immunol, 2002; 168: 861-68
21. Ivanov II, McKenzie BS, Zhou L et al: The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell, 2006; 126: 1121-33
22. Yang J, Chu Y, Yang X et al: Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum, 2009; 60: 1472-83
23. International Study Group for Behçet's disease: Criteria for diagnosis of Behçet's disease. Lancet, 1990; 335: 1078-80
24. Lawton G, Bhakta BB, Chamberlain A, Tenant A: The Behçet's disease activity index. Rheumatol, 2004; 43: 73-78
25. Bombardier C, Gladman DD, Urowitz MB et al: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992; 35: 630-40
26. McDonald WI, Compston A, Edan G et al: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol, 2001; 50: 121-27
27. Hamzaoui K, Houman H, Hamzaoui A. Serum BAFF levels and skin mRNA expression in patients with Behçet's disease. Clin Exp Rheumatol, 2008; 26(4 Suppl.50): S64-71
28. Smith E, Prasad KM, Butcher M et al: Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation, 2010; 121(15): 1746-55
29. Raziuddin S, Al-Dalaan A, Bahabri S et al: Divergent cytokine production profile in Behcet's disease: altered Th1/Th2 cell cytokine pattern. J Rheumatol, 1998; 25: 329-33
30. Hamzaoui K, Borhani Haghighi A, Ben Ghorbel I, Houman H: RORC and Foxp3 in cerebrospinalk fluid of patients with neuro-Behçet's disease. J Neuroimmunol, 2011; Epub ahead of print
31. Chi W, Zhu X, Yang P et al: Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci, 2008; 49: 3058-64
32. Kulaber A, Tugal-Tutkun I, Yentür SP et al: Pro-inflammatory cellular immune response in Behçet's disease. Rheumatol Int, 2007; 27(12): 1113-18
33. Dilek K, Ozçimen AA, Saricaǒglu H et al: Cytokine gene polymorphisms in Behçet's disease and their association with clinical and laboratory findings. Clin Exp Rheumatol, 2009; 27: S73-78
34. Jandus C, Bioley G, Rivals JP et al: Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum, 2008; 58: 2307-17
35. Alayli G, Aydin F, Coban AY et al: T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet's disease. Clin Rheumatol, 2007; 26: 1299-305
36. Steinman L: A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med, 2007; 13: 139-45
37. Kolls JK, Linden A: Interleukin-17 family members and inflammation. Immunity, 2004; 21: 467-76
38. Melikoglu M, Uysal S, Krueger JG et al: Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers. J Immunol, 2006; 177: 6415-21
39. Aridogan BC, Yildirim M, Baysal V et al: Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease. J Dermatol, 2003; 30: 602-7
40. Keller M, Spanou Z, Schaerli P et al: T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol, 2005; 175: 7678-86
41. Korn T, Reddy J, Gao W et al: Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med, 2007; 13: 423-31
42. Dalghous AM, Freysdottir J, Fortune F: Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD. Scand J Rheumatol, 2006; 35: 472-75
43. Imamura Y, Kurokawa MS, Yoshikawa H et al: Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol, 2005; 139: 371-78
44. Deknuydt F, Bioley G, Valmori D, Ayyoub M: IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol, 2009; 131: 298-307
45. Zhou L, Lopes JE, Mark MW et al: TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature, 2008; 453: 236-40